Dr. Malecela joined us to celebrate Togo’s elimination of lymphatic filariasis in 2019. A Tribute to Dr. Mwele Malecela: A Colleague, a Collaborator, and
Summer and autumn have seen the careful resumption of Mectizan® mass drug administration (MDA) campaigns around the world with COVID-19 safety measures in place.
Determination, innovation and adaptation can keep lymphatic filariasis elimination on track October 21, 2021 World Health Organization COVID-19 has severely disrupted the implementation of
Video recordings from “The Power of Partnership: Defeating Onchocerciasis” symposium are ready to view. Featuring 29 speakers from diverse aspects of the campaign, the
Déclaration du Comité d’Experts de Mectizan (CEM) sur l’utilisation du Mectizan® : Le Comité rappelle à nos pays partenaires que le Mectizan® est exclusivement
A Mectizan Expert Committee (MEC) Statement on the use of Mectizan® during the COVID-19 pandemic: The MEC reminds country partners that Mectizan is donated only
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications
On June 14, 2018, the US FDA approved moxidectin as a treatment for onchocerciasis (river blindness). We applaud Medicines Development for Global Health (MDGH)
The Carter Center and partners are working with Nigeria’s Ministry of Health to eliminate river blindness in nine of the country’s states, including Plateau,
Article, Business Daily, February 7, 2018. SUMMARY A 2016 study shows the country can save over Sh193bn by 2030 through elimination of trachoma, bilharzia,
Five years after the policy change from river blindness control to elimination, the Ministry of Health would like to announce the interruption of transmission
A slideshow highlighting a few of the thousands of volunteers trained as community-directed distributors for the River Blindness Elimination Program in Nigeria. Presentation. The
